Data from up to 42 months of treatment reinforce lucerastat’s potential as a first-in-class oral substrate reduction therapy addressing key unmet needs across the Fabry populationThe company is ...

JCR Pharmaceuticals Co., Ltd. (TSE 4552; "JCR"), a global specialty biopharmaceutical company dedicated to developing therapies for rare and genetic diseases, announced today that it will present data ...

Data from up to 42 months of treatment reinforce lucerastat's potential as a first-in-class oral substrate reduction therapy addressing key unmet needs across the Fabry populationThe company is finali ...

Postoperative-neuromodulation-therapy-reduces-chronic-knee-pain-and-improves-mobility-up-to-one-year-after-knee-replacement-surgery ...

Lisa Rinna’s daughter, Amelia, is opening up like never before — and she’s not the only one in her family getting candid.

Lisa Rinna’s daughter, Amelia, is opening up like never before — and she’s not the only one in her family getting candid. In a deeply personal conversation about beauty, pressure, and painful lessons, ...

Analyzing molecular changes in two types of peripheral nerves that are affected in diabetic peripheral neuropathy – the sural, which carry sensory signals, and the tibial, which carry both sensory and ...

We’ve turned survival responses into a black-and-white idea: pathology or wisdom. This is what we miss when we do that, and ...

Neurological diseases affect the nervous system, including the brain, spinal cord, and peripheral nerves that carry signals throughout your body. These conditions can disrupt movement, thinking, mood, ...

We often think of ourselves as more capable than we really are. For example, according to this survey, four in five Americans ...

Cortigent is a leading developer of brain interface devices based on precision neurostimulation technology The company’s new ...